Mary Fisher's Net Worth

$3.2 Million

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Mary Fisher?

Mary Fisher has an estimated net worth of $3.2 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, Sientra, Inc., OvaScience, Inc., ACORDA THERAPEUTICS INC, and Dermata Therapeutics, Inc..

SEC CIK

Mary Fisher's CIK is 0001272360

Past Insider Trading and Trends

2015 was Mary Fisher's most active year for acquiring shares with 12 total transactions. Mary Fisher's most active month to acquire stocks was the month of May. 2007 was Mary Fisher's most active year for disposing of shares, totalling 132 transactions. Mary Fisher's most active month to dispose stocks was the month of December. 2015 saw Mary Fisher paying a total of $961,421.41 for 107,902 shares, this is the most they've acquired in one year. In 2015 Mary Fisher cashed out on 165,204 shares for a total of $2,596,797.26, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Zeltiq Aesthetics Inc No price found

Investor

Mary Fisher used to own units in Common Stock but no longer holds any shares there.acquired a total of 94,587 shares in Zeltiq Aesthetics Inc at a cost of $1,025,887.83, Mary also disposed a total of 94,587 shares of Zeltiq Aesthetics Inc equalling to $2,652,687.26.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.12K
—
—
0
Apr 28
Form 4
+158.02%
6.2K
$28.23
$174,997.77
10.12K
Jun 16
Form 4
-32.20%
-1.86K
$30.00
-$55,890.00
3.92K
Scheduled
Apr 13
Form 4
—
0
$23.81
-$379,596.52
5.79K
Scheduled
Dec 7 - Dec 8
Form 4
+15.81%
790
—
—
5.79K
Jul 22
Form 4
∞
5K
—
—
5K
Jun 17
Form 4
—
0
$19.20
-$1,366,310.68
0
Scheduled
Jan 26
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

Sientra, Inc. (SIEN) No price found

Investor

Mary Fisher owns 58,971 units of Common Stock (RSUs) and 19,581 units of Common Stock. In the year 2019 Mary Fisher filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+158.29%
12K
—
—
19.58K
Jun 15
Form 4
+136.21%
103.31K
—
—
179.15K
Jun 9
Form 4
+28.61%
16.87K
—
—
75.84K
Jun 10
Form 4
+88.68%
27.72K
—
—
58.97K
Jun 5
Form 4
+161.89%
19.32K
—
—
31.25K
Jun 14
Form 4
∞
11.93K
$12.71
$151,681.14
11.93K
Jan 1
Form 3
—
0
—
—
0
No matching records found

OvaScience, Inc. (TPST) Snapshot price: $1.25

Investor

Mary Fisher owns 3,319 units of Common Stock which is worth $4,148.75. In the year 2013 Mary Fisher filed a total of 24 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.98%
355
—
—
3.32K
Dec 7
Form 4
+18.22%
6.85K
—
—
44.46K
Sep 28
Form 4
—
0
—
—
0
Jul 4
Form 4
+17.17%
5.51K
—
—
37.61K
Jun 29
Form 4
+23.77%
6.17K
—
—
32.1K
Mar 30
Form 4
+15.97%
3.57K
—
—
25.93K
Dec 29
Form 4
+18.69%
3.52K
—
—
22.36K
Sep 29
Form 4
+20.50%
3.21K
—
—
18.84K
Jun 30
Form 4
—
0
—
—
0
Jun 21
Form 4
+20.62%
2.67K
—
—
15.64K
Mar 31
Form 4
+33.69%
3.27K
$1.53
$4,998.51
12.96K
Dec 30
Form 4
+7.76%
698
—
—
9.7K
Sep 30
Form 4
+11.93%
959
—
—
9K
Jun 30
Form 4
—
0
—
—
0
Jun 2
Form 4
+7.00%
526
—
—
8.04K
Mar 31
Form 4
+7.30%
511
—
—
7.51K
Dec 31
Form 4
+9.17%
588
—
—
7K
Sep 30
Form 4
+1,936.51%
6.1K
$16.49
$100,589.00
6.42K
Sep 9
Form 4
+120.28%
172
$28.93
$4,975.96
315
Jun 30
Form 4
—
0
—
—
0
Jun 4
Form 4
∞
143
$34.73
$4,966.39
143
Mar 31
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 7
Form 3
—
0
—
—
0
No matching records found

ACORDA THERAPEUTICS INC (ACOR) No price found

Chief Operating Officer

Mary Fisher owns 57,230 units of Restricted stock. In the year 2006 Mary Fisher filed a total of 14 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.59%
-7.50K
$17.67
-$132,504.00
57.23K
Scheduled
Jul 2
Form 4
-10.38%
-7.50K
$19.61
-$147,038.39
64.73K
Scheduled
Jun 1
Form 4
-9.41%
-7.50K
$24.24
-$181,769.05
72.23K
Scheduled
May 1
Form 4
-8.60%
-7.50K
$19.14
-$143,523.83
79.73K
Scheduled
Apr 2
Form 4
-7.92%
-7.50K
$20.96
-$157,231.00
87.23K
Scheduled
Mar 1
Form 4
—
0
—
—
0
Feb 14
Form 4
-7.34%
-7.50K
$17.60
-$131,993.56
94.73K
Scheduled
Feb 1
Form 4
-0.78%
-800.00
$15.33
-$12,265.00
102.23K
Scheduled
Jan 3
Form 4
-6.11%
-6.70K
$15.64
-$104,811.00
103.03K
Scheduled
Jan 3
Form 4
-6.40%
-7.50K
$18.93
-$141,985.00
109.73K
Scheduled
Dec 1
Form 4
-25.44%
-40.00K
$16.05
-$641,867.35
117.23K
Scheduled
Nov 6
Form 4
—
0
—
—
0
Sep 25
Form 4
—
0
—
—
0
Feb 15
Form 3
—
0
—
—
0
No matching records found

Dermata Therapeutics, Inc. (DRMA) Snapshot price: $1.59

Investor

Mary Fisher owns 23,443 units of Common Stock which is worth $37,274.37. From 2021 to 2024 Mary Fisher acquired a total of 23,443 shares in Dermata Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
+71.96%
9.81K
—
—
23.44K
Oct 6
Form 4
+170.98%
8.6K
—
—
13.63K
Jul 7
Form 4
∞
5.03K
—
—
5.03K
Apr 7
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Aug 17
Form 3
—
0
—
—
0
No matching records found